Page last updated: 2024-09-05

lapatinib and Adenocarcinoma, Scirrhous

lapatinib has been researched along with Adenocarcinoma, Scirrhous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aono, T; Iwase, K; Nakamura, Y; Nomura, M; Tanaka, Y	1

Other Studies

1 other study(ies) available for lapatinib and Adenocarcinoma, Scirrhous

Article	Year
[Two cases of HER2-positive advanced or metastatic breast cancer, responding to lapatinib and capecitabine]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:11 Topics: Adenocarcinoma, Scirrhous; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Deoxycytidine; Female; Fluorouracil; Humans; Lapatinib; Lung Neoplasms; Lymph Node Excision; Mastectomy; Middle Aged; Quinazolines; Receptor, ErbB-2	2010

Article

Year

[Two cases of HER2-positive advanced or metastatic breast cancer, responding to lapatinib and capecitabine].

Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:11

Topics: Adenocarcinoma, Scirrhous; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Deoxycytidine; Female; Fluorouracil; Humans; Lapatinib; Lung Neoplasms; Lymph Node Excision; Mastectomy; Middle Aged; Quinazolines; Receptor, ErbB-2

2010